Dysesthesia Across Trials TRIUMPH-4 revealed dysesthesia (tingling, burning, or numbness) in 20.9% of participants at 12mg (8.8% at 9mg), versus 0.7% placebo
Measurement of GLP-1
Wegovy (injection) The list price of a 28-day supply of Wegovy is $1,349.02
Originally identified for their role in glucose homeostasis, these compounds have become the primary focus of contemporary longitudinal studies involving obesity, neurodegeneration, and cardiovascular health
Congress Asks Federal FDA to Act Finally, on July 25, 2025, a bipartisan group of more than 80 congressional representatives sent a letter to FDA Commissioner Martin Makary raising concerns regarding an alleged surge in illegal and counterfeit anti-obesity medication (AOMs), which include semaglutide and tirzepatide, entering the United States from foreign entities
Without the medication, people with insulin resistance or type 2 diabetes often see fasting glucose and HbA1c climb back toward pre-treatment levels